Related Experiment Video
Updated: Dec 12, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.0K
Expanding Pharmacotherapy Data Collection, Analysis, and Implementation in ERAS® Programs-The Methodology of an
Eric Johnson1, Richard Parrish Ii2, Gregg Nelson3
1Department of Pharmacy Services, University of Kentucky, Lexington, KY 40506, USA.
Healthcare (Basel, Switzerland)
|August 7, 2020
Summary
This study examines medication use in Enhanced Recovery After Surgery (ERAS) protocols for colorectal and gynecologic/oncology patients. It aims to improve pharmacotherapy data collection and minimize variability to enhance patient outcomes.
Area of Science:
- Perioperative Medicine
- Surgical Outcomes Research
- Pharmacotherapy
Background:
- Enhanced Recovery After Surgery (ERAS) guidelines have transformed perioperative care since 2012.
- ERAS protocols encompass 22 clinical interventions, with nine focusing on pharmacotherapy.
- Current ERAS data collection may lack pharmacotherapy specificity.
Purpose of the Study:
- To enhance pharmacotherapy data collection within the ERAS Interactive Audit System (EIAS).
- To investigate the link between medication regimens and patient outcomes in elective colorectal and gynecologic/oncology surgery.
- To reduce pharmacotherapy variability in ERAS protocols for these surgical cohorts.
Main Methods:
- Retrospective comparative pharmacotherapy project.
- Utilizes the ERAS Interactive Audit System (EIAS) for data collection.
- Focuses on elective colorectal and gynecologic/oncology surgical patients.
Main Results:
- Primary outcomes include surgical site infections, venous thromboembolism, and post-operative nausea/vomiting.
- Secondary outcomes encompass patient satisfaction, complication rates, length of stay, and readmission rates (7 and 30 days).
Conclusions:
- Improved pharmacotherapy data in ERAS can optimize perioperative care.
- Standardizing medication use may lead to better patient outcomes and reduced complications.
- Further research is needed to refine pharmacotherapy recommendations within ERAS guidelines.
Keywords:
collaborationcolorectalenhanced recoverygynecologicalinfection, surgical woundperioperative carepharmacy, clinicalpost-operative nausea and vomitingprophylaxissurgeonsurgerythromboembolismvenousMore Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
16.5K
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.7K
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
587
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
587
01:20Measurement of Bioavailability: Pharmacodynamic Methods
118
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
118
01:19Pharmacovigilance
1.5K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
81
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
81
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:26Drug Administration and Therapy Phases: Overview
1.0K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.0K